Arcadia Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Arcadia Biosciences, Inc.‘s stocks are currently a part of 6 hedge funds’ portfolios, which represents 26.31% of the total amount of its stocks outstanding. This makes up a total of 3.94K shares of Arcadia Biosciences, Inc.. Compared to the previous quarter, the number fell by -93.34% or -55.23K shares fewer. As for the holding position changes, 200% (12) closed the holdings completely. 6 hedge funds are new holders of Arcadia Biosciences, Inc. stock in Q1 2023, it is 100% of total holders.
Hedge funds holding Arcadia Biosciences (Q2 2018 – Q1 2023)
| Q2 2018 | 12 |
|---|---|
| Q3 2018 | 12 |
| Q4 2018 | 10 |
| Q1 2019 | 10 |
| Q2 2019 | 14 |
| Q3 2019 | 17 |
| Q4 2019 | 14 |
| Q1 2020 | 11 |
| Q2 2020 | 14 |
| Q3 2020 | 18 |
| Q4 2020 | 17 |
| Q1 2021 | 22 |
| Q2 2021 | 25 |
| Q3 2021 | 18 |
| Q4 2021 | 24 |
| Q1 2022 | 23 |
| Q2 2022 | 18 |
| Q3 2022 | 21 |
| Q4 2022 | 26 |
| Q1 2023 | 6 |
Hedge funds changes in Arcadia Biosciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 6 | 4 | 1 | 5 | -4 |
|---|---|---|---|---|---|
| Q3 2018 | 5 | 3 | 1 | 5 | -2 |
| Q4 2018 | 2 | 1 | 2 | 4 | 1 |
| Q1 2019 | 3 | 2 | 1 | 3 | 1 |
| Q2 2019 | 8 | 2 | 0 | 4 | 0 |
| Q3 2019 | 8 | 4 | 1 | 5 | -1 |
| Q4 2019 | 6 | 3 | 3 | 9 | -7 |
| Q1 2020 | 5 | 4 | 0 | 6 | -4 |
| Q2 2020 | 5 | 3 | 2 | 3 | 1 |
| Q3 2020 | 5 | 6 | 2 | 1 | 4 |
| Q4 2020 | 1 | 7 | 4 | 2 | 3 |
| Q1 2021 | 7 | 9 | 2 | 2 | 2 |
| Q2 2021 | 9 | 9 | 4 | 6 | -3 |
| Q3 2021 | 1 | 8 | 3 | 8 | -2 |
| Q4 2021 | 10 | 4 | 5 | 4 | 1 |
| Q1 2022 | 5 | 7 | 6 | 6 | -1 |
| Q2 2022 | 2 | 5 | 8 | 7 | -4 |
| Q3 2022 | 6 | 6 | 5 | 3 | 1 |
| Q4 2022 | 8 | 6 | 9 | 3 | 0 |
| Q1 2023 | 6 | 0 | 0 | 12 | -12 |
Hedge funds changes in Arcadia Biosciences stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 274,000 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 88,000 | 139,000 |
| Q1 2021 | 2,394,000 | 1,442,000 |
| Q2 2021 | 1,328,000 | 2,737,000 |
| Q3 2021 | 619,000 | 790,000 |
| Q4 2021 | 65,000 | 80,000 |
| Q1 2022 | 348,000 | 122,000 |
| Q2 2022 | 53,000 | 36,000 |
| Q3 2022 | 7,000 | 0 |
| Q4 2022 | 3,496 | 136 |
| Q1 2023 | 0 | 0 |